About this trial
This Type 1 hybrid effectiveness-implementation randomized controlled trial, A Remote Intervention to Prevent Overdose among People who Use Stimulants and/or Opioids, aims to address the United States opioid crisis driven by fentanyl and other synthetic opioids by reducing overdose rates. It is supported by and included in the HEAL Initiative. This study would be the first national, fully remote trial to assess the impact of remote education on overdose outcomes, using a novel 2x2 design crossing remote education with remote access support. This research will inform scalability around remote education programs to address the nation's opioid overdose crisis.
Eligibility criteria
Qualifiers
18 years old
English-speaking and reading
Report using illicit opioids and/or stimulants (including counterfeit pills) within the past 3 months per the ASSIST
Able and willing to provide informed consent
Disqualifiers
Living in a restricted environment (e.g., prison)
Trial design
Treatments tested in this trial
- Overdose prevention resources
- Overdose prevention education
Treatment groups
Sponsors and collaborators
University of Alabama at Birmingham
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator